{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:13:04Z","timestamp":1791267184370,"version":"4.1.0"},"reference-count":44,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III (ISCIII)","doi-asserted-by":"publisher","award":["18\/1234"],"award-info":[{"award-number":["18\/1234"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III (ISCIII)","doi-asserted-by":"publisher","award":["2020\/0197782"],"award-info":[{"award-number":["2020\/0197782"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ONCE","award":["18\/1234"],"award-info":[{"award-number":["18\/1234"]}]},{"name":"ONCE","award":["2020\/0197782"],"award-info":[{"award-number":["2020\/0197782"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>A clinical and genetic study was conducted with pediatric patients and their relatives with optic atrophy 1 (OPA1) mutations to establish whether there is a genotype\u2013phenotype correlation among the variants detected within and between families. Eleven children with a confirmed OPA1 mutation were identified during the study period. The main initial complaint was reduced visual acuity (VA), present in eight patients of the cohort. Eight of eleven patients had a positive family history of optic atrophy. The mean visual acuity at the start of the study was 0.40 and 0.44 LogMAR in the right and left eye, respectively. At the end of the study, the mean visual acuity was unchanged. Optical coherence tomography during the first visit showed a mean retinal nerve fiber layer thickness of 81.6 microns and 80.5 microns in the right and left eye, respectively; a mean ganglion cell layer of 52.5 and 52.4 microns, respectively, and a mean central macular thickness of 229.5 and 233.5 microns, respectively. The most common visual field defect was a centrocecal scotoma, and nine out of eleven patients showed bilateral temporal disc pallor at baseline. Sequencing of OPA1 showed seven different mutations in the eleven patients, one of which, NM_130837.3: c.1406_1407del (p.Thr469LysfsTer16), has not been previously reported. Early diagnosis of dominant optic atrophy is crucial, both for avoiding unnecessary consultations and\/or treatments and for appropriate genetic counseling.<\/jats:p>","DOI":"10.3390\/cimb45010030","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T05:29:48Z","timestamp":1672896588000},"page":"465-478","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["OPA1 Dominant Optic Atrophy: Diagnostic Approach in the Pediatric Population"],"prefix":"10.3390","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8049-0238","authenticated-orcid":false,"given":"Natalia","family":"Arruti","sequence":"first","affiliation":[{"name":"Department of Pediatric Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain"},{"name":"European Reference Network on Eye Diseases (ERN-EYE), La Paz University Hospital, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0118-5003","authenticated-orcid":false,"given":"Patricia","family":"Rodr\u00edguez-Solana","sequence":"additional","affiliation":[{"name":"Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6972-0880","authenticated-orcid":false,"given":"Mar\u00eda","family":"Nieves-Moreno","sequence":"additional","affiliation":[{"name":"Department of Pediatric Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain"},{"name":"European Reference Network on Eye Diseases (ERN-EYE), La Paz University Hospital, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Guerrero-Carretero","sequence":"additional","affiliation":[{"name":"Department of Pediatric Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6690-1619","authenticated-orcid":false,"given":"\u00c1ngela","family":"del Pozo","sequence":"additional","affiliation":[{"name":"Biomedical Research Center in the Rare Diseases Network (CIBERER), Carlos II Health Institute (ISCIII), 28029 Madrid, Spain"},{"name":"Clinical Bioinformatics Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, CIBERER, Hospital Universitario La Paz, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria E. F.","family":"Monta\u00f1o","sequence":"additional","affiliation":[{"name":"Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain"},{"name":"Biomedical Research Center in the Rare Diseases Network (CIBERER), Carlos II Health Institute (ISCIII), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Santos-Simarro","sequence":"additional","affiliation":[{"name":"Biomedical Research Center in the Rare Diseases Network (CIBERER), Carlos II Health Institute (ISCIII), 28029 Madrid, Spain"},{"name":"Clinical Genetics Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, CIBERER, Hospital Universitario La Paz, 28046 Madrid, Spain"},{"name":"Molecular Diagnostics and Clinical Genetics Unit, Health Research Institute of the Balearic Islands (IdISBa), Hospital Universitari Son Espases, 07120 Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Rikeros-Orozco","sequence":"additional","affiliation":[{"name":"Clinical Genetics Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, CIBERER, Hospital Universitario La Paz, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luna","family":"Delgado-Mora","sequence":"additional","affiliation":[{"name":"Clinical Genetics Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, CIBERER, Hospital Universitario La Paz, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8080-8629","authenticated-orcid":false,"given":"Elena","family":"Vallesp\u00edn","sequence":"additional","affiliation":[{"name":"European Reference Network on Eye Diseases (ERN-EYE), La Paz University Hospital, 28046 Madrid, Spain"},{"name":"Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain"},{"name":"Biomedical Research Center in the Rare Diseases Network (CIBERER), Carlos II Health Institute (ISCIII), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4108-2383","authenticated-orcid":false,"given":"Susana","family":"Noval","sequence":"additional","affiliation":[{"name":"Department of Pediatric Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain"},{"name":"European Reference Network on Eye Diseases (ERN-EYE), La Paz University Hospital, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.spen.2017.06.001","article-title":"Dominant Optic Atrophy and Leber\u2019s Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches","volume":"24","author":"Chun","year":"2017","journal-title":"Semin. Pediatr. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Zeviani, M., and Carelli, V. (2022). Mitochondrial Retinopathies. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010210"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Weisschuh, N., Schimpf-Linzenbold, S., Mazzola, P., Kieninger, S., Xiao, T., Kellner, U., Neuhann, T., Kelbsch, C., Tonagel, F., and Wilhelm, H. (2021). Mutation spectrum of the OPA1 gene in a large cohort of patients with suspected dominant optic atrophy: Identification and classification of 48 novel variants. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0253987"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.celrep.2017.05.073","article-title":"OPA1 Isoforms in the Hierarchical Organization of Mitochondrial Functions","volume":"19","author":"Mishra","year":"2017","journal-title":"Cell Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e7285","DOI":"10.7717\/peerj.7285","article-title":"Structural and evolutionary characteristics of dynamin-related GTPase OPA1","volume":"7","author":"Li","year":"2019","journal-title":"PeerJ"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"571479","DOI":"10.3389\/fnins.2020.571479","article-title":"Optimized OPA1 Isoforms 1 and 7 Provide Therapeutic Benefit in Models of Mitochondrial Dysfunction","volume":"14","author":"Maloney","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1212\/CON.0000000000000769","article-title":"Toxic-Metabolic and Hereditary Optic Neuropathies","volume":"25","author":"Oliveira","year":"2019","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/02713683.2019.1567792","article-title":"Optical Coherence Tomography of the Retinal Ganglion Cell Complex in Leber\u2019s Hereditary Optic Neuropathy and Dominant Optic Atrophy","volume":"44","author":"Asanad","year":"2019","journal-title":"Curr. Eye Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/79936","article-title":"Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy","volume":"26","author":"Delettre","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.mito.2017.07.004","article-title":"Incomplete penetrance in mitochondrial optic neuropathies","volume":"36","author":"Caporali","year":"2017","journal-title":"Mitochondrion"},{"key":"ref_11","first-page":"559","article-title":"Autosomal dominant optic atrophy with OPA1 gene mutations accompanied by auditory neuropathy and other systemic complications in a Japanese cohort","volume":"25","author":"Nakamura","year":"2019","journal-title":"Mol. Vis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/acn3.51026","article-title":"Idebenone increases chance of stabilization\/recovery of visual acuity in OPA1-dominant optic atrophy","volume":"7","author":"Romagnoli","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1093\/brain\/aws280","article-title":"Idebenone treatment in patients with OPA1-mutant dominant optic atrophy","volume":"136","author":"Barboni","year":"2013","journal-title":"Brain"},{"key":"ref_14","first-page":"e56","article-title":"Multicenter Spanish study of spectral-domain optical coherence tomography in normal children","volume":"91","author":"Noval","year":"2013","journal-title":"Acta Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1242\/jcs.181008","article-title":"Nonsense-mediated mRNA decay in humans at a glance","volume":"129","author":"Kurosaki","year":"2016","journal-title":"J. Cell Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/humu.20607","article-title":"Comprehensive cDNA study and quantitative transcript analysis of mutant OPA1 transcripts containing premature termination codons","volume":"29","author":"Schimpf","year":"2008","journal-title":"Hum. Mutat."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13023-019-1187-1","article-title":"OPA1: 516 unique variants and 831 patients registered in an updated centralized Variome database","volume":"14","author":"Lenaers","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_18","first-page":"912","article-title":"Targeted next-generation sequencing extends the mutational spectrums for OPA1 mutations in Chinese families with optic atrophy","volume":"25","author":"Wang","year":"2019","journal-title":"Mol. Vis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1399-0004.2011.01751.x","article-title":"High frequency of OPA1 mutations causing high ADOA prevalence in south-eastern Sicily, Italy","volume":"82","author":"Gallus","year":"2012","journal-title":"Clin. Genet."},{"key":"ref_20","first-page":"691","article-title":"First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation","volume":"20","author":"Kamakari","year":"2014","journal-title":"Mol. Vis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"E692","DOI":"10.1002\/humu.21025","article-title":"Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations","volume":"30","author":"Bonneau","year":"2009","journal-title":"Hum. Mutat."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00415-005-0057-z","article-title":"A novel mutation producing premature termination codon at the OPA1 gene causes autosomal dominant optic atrophy","volume":"253","author":"Cardaioli","year":"2006","journal-title":"J. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1167\/iovs.14-14953","article-title":"Mutation Screening of Mitochondrial DNA as Well as OPA1 and OPA3 in a Chinese Cohort With Suspected Hereditary Optic Atrophy","volume":"55","author":"Chen","year":"2014","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jns.2017.09.018","article-title":"Genotype-phenotype and OCT correlations in Autosomal Dominant Optic Atrophy related to OPA1 gene mutations: Report of 13 Italian families","volume":"382","author":"Pretegiani","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/aos.13285","article-title":"OPA1 analysis in an international series of probands with bilateral optic atrophy","volume":"95","author":"Liskova","year":"2017","journal-title":"Acta Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/APO.0b013e31824a65b1","article-title":"Long-Term Follow-Up Study of Autosomal Dominant Optic Atrophy in an Australian Population","volume":"1","author":"Chang","year":"2012","journal-title":"Asia-Pac. J. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Lin, C.-W., Huang, C.-W., Luo, A.C., Chou, Y.-T., Huang, Y.-S., Chen, P.-L., and Chen, T.-C. (2021). Genetic Spectrum and Characteristics of Hereditary Optic Neuropathy in Taiwan. Genes, 12.","DOI":"10.3390\/genes12091378"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-7-46","article-title":"Dominant optic atrophy","volume":"7","author":"Lenaers","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/ICU.0000000000000314","article-title":"Dominant optic atrophy: Updates on the pathophysiology and clinical manifestations of the optic atrophy 1 mutation","volume":"27","author":"Chun","year":"2016","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.ophtha.2011.02.027","article-title":"Retinal Nerve Fiber Layer Thickness in Dominant Optic Atrophy","volume":"118","author":"Barboni","year":"2011","journal-title":"Ophthalmology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/eye.2011.2","article-title":"Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations","volume":"25","author":"Bailie","year":"2011","journal-title":"Eye"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1755-3768.2008.01469.x","article-title":"Axonal loss occurs early in dominant optic atrophy","volume":"88","author":"Milea","year":"2009","journal-title":"Acta Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/aos.13588","article-title":"Thickness mapping of individual retinal layers and sectors by Spectralis SD-OCT in Autosomal Dominant Optic Atrophy","volume":"96","author":"Corajevic","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/79944","article-title":"OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28","volume":"26","author":"Alexander","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e2309","DOI":"10.1038\/cddis.2016.160","article-title":"Mitochondrial dysfunction in an Opa1(Q285STOP) mouse model of dominant optic atrophy results from Opa1 haploinsufficiency","volume":"7","author":"Kushnareva","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/cdd.2012.128","article-title":"Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity","volume":"20","author":"Kushnareva","year":"2013","journal-title":"Cell Death Differ."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cell.2006.06.025","article-title":"OPA1 Controls Apoptotic Cristae Remodeling Independently from Mitochondrial Fusion","volume":"126","author":"Frezza","year":"2006","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/jmedgenet-2013-101774","article-title":"A novel heterozygous OPA3 mutation located in the mitochondrial target sequence results in altered steady-state levels and fragmented mitochondrial network","volume":"50","author":"Grau","year":"2013","journal-title":"J. Med. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.mito.2018.07.006","article-title":"Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy","volume":"46","author":"Ham","year":"2019","journal-title":"Mitochondrion"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s00415-015-7849-6","article-title":"A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family","volume":"262","author":"Ahmad","year":"2015","journal-title":"J. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1111\/jcmm.13149","article-title":"Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy","volume":"21","author":"Kane","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.gim.0000214299.61930.c0","article-title":"OPA1 mutations and mitochondrial DNA haplotypes in autosomal dominant optic atrophy","volume":"8","author":"Han","year":"2006","journal-title":"Genet. Med."},{"key":"ref_43","first-page":"2760","article-title":"Variation in OPA1 does not explain the incomplete penetrance of Leber hereditary optic neuropathy","volume":"16","author":"Hudson","year":"2010","journal-title":"Mol. Vis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/45\/1\/30\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:59:59Z","timestamp":1760119199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/45\/1\/30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,5]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["cimb45010030"],"URL":"https:\/\/doi.org\/10.3390\/cimb45010030","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,5]]}}}